Ancora Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.65K | Buy |
|
|||||
|
2025
Q1 | $8.43K | Sell |
|
|||||
|
2024
Q4 | $71.3K | Buy |
|
|||||
|
2024
Q3 | $75.8K | Sell |
|
|||||
|
2024
Q2 | $2.16M | Sell |
|
|||||
|
2024
Q1 | $4.73M | Sell |
|
|||||
|
2023
Q4 | $4.17M | Sell |
|
|||||
|
2023
Q3 | $3.59M | Sell |
|
|||||
|
2023
Q2 | $5.14M | Buy |
|
|||||
|
2023
Q1 | $2.13M | Sell |
|
|||||
|
2022
Q4 | $2.89M | Buy |
|
|||||
|
2022
Q3 | $1.01M | Buy |
|
|||||
|
2022
Q2 | $140K | Sell |
|
|||||
|
2022
Q1 | $206K | Sell |
|
|||||
|
2021
Q4 | $3.96M | Sell |
|
|||||
|
2021
Q3 | $7.46M | Sell |
|
|||||
|
2021
Q2 | $7.59M | Sell |
|
|||||
|
2021
Q1 | $6.04M | Sell |
|
|||||
|
2020
Q4 | $5.64M | Sell |
|
|||||
|
2020
Q3 | $5.16M | Sell |
|
|||||
|
2020
Q2 | $6.75M | Sell |
|
|||||
|
2020
Q1 | $7.86M | Buy |
|
|||||
|
2019
Q4 | $8.88M | Sell |
|
|||||
|
2019
Q3 | $7.69M | Buy |
|
|||||
|
2019
Q2 | $9.28M | Buy |
|